Biosimilar G-CSF (filgrastim) is also efficient for peripheral blood stem cell mobilisation and no cryopreserved autologous transplantation

被引：0
|
作者：
Yafour, N. [1 ]
Osmani, S. [1 ]
Talhi, S. [1 ]
Brahimi, M. [1 ]
Hebbar, A. [1 ]
Bekadja, S. [1 ]
Mehalli, S. [1 ]
Benmir, I. [1 ]
Arabi, A. [1 ]
Bouhass, R. [1 ]
Bekadja, M. A. [1 ]
机构：
[1] Univ Oran, Oran, DZ, Algeria
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [11] Retrospective Analysis of Autologous Peripheral Blood Stem Cell Mobilization Using G-CSF Including Biosimilar
    Tsukada, Nobuhiro
    Ikeda, Masahiro
    Shingaki, Sumito
    Miyazaki, Kanji
    Meshitsuka, Sohsuke
    Yoshiki, Yumiko
    Abe, Yu
    Konoma, Yuko
    Iki, Seiko
    Suzuki, Kenshi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S137
  • [12] Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in hematological malignancies using biosimilar G-CSF
    Michael, S.
    Hoffmann, J. -M.
    Lorenz, K.
    Publicover, A.
    Schmitt, A.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S348 - S348
  • [13] Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G-CSF
    Schmitt, M.
    Hoffmann, J. -M.
    Lorenz, K.
    Publicover, A.
    Schmitt, A.
    Nagler, A.
    VOX SANGUINIS, 2016, 111 (02) : 178 - 186
  • [14] Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation
    Pahnke, Simon
    Egeland, Torstein
    Halter, Jorg
    Hagglund, Hans
    Shaw, Bronwen E.
    Woolfrey, Ann E.
    Szer, Jeff
    BONE MARROW TRANSPLANTATION, 2019, 54 (06) : 858 - 866
  • [15] Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation
    Simon Pahnke
    Torstein Egeland
    Jörg Halter
    Hans Hägglund
    Bronwen E Shaw
    Ann E Woolfrey
    Jeff Szer
    Bone Marrow Transplantation, 2019, 54 : 858 - 866
  • [16] Peripheral blood stem cell mobilisation in related and unrelated donors with G-CSF
    Schmetzer, B
    Schilz, A
    Herrmann, D
    Bender, M
    Bischoff, M
    Günzelmann, S
    Kirsten, D
    Rudolphi, M
    Roemer, E
    Sanchez, H
    Blau, W
    Pauser, AA
    BONE MARROW TRANSPLANTATION, 1998, 22 : S21 - S21
  • [17] Peg-Filgrastim after autologous peripheral blood stem cell transplantation:: a matched-pair analysis and kinetics of G-CSF
    Piccirillo, N
    De Matteis, S
    Laurenti, L
    Chiusolo, P
    De Vita, S
    Sorà, F
    Putzulu, R
    Reddiconto, G
    Farina, G
    d'Onofrio, G
    Leone, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S102 - S102
  • [18] G-CSF administration after autologous peripheral blood stem cell transplantation (PBSCT) - Yes or no?
    Henon, P
    Ojeba-Uribe, M
    Arkam, Y
    Bourderont, D
    Sovalat, H
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 136 - 136
  • [19] Application of the G-CSF biosimilar Ratiograstim® for the mobilisation of peripheral stem cells in healthy donors
    Schmitt, M.
    Diestel, L.
    Xu, X.
    Borchert, K.
    Glaeser, D.
    Hilgendorf, I
    Scheuerlein, R.
    Freund, M.
    Schmitt, A.
    ONKOLOGIE, 2011, 34 : 280 - 280
  • [20] Allogeneic transplantation using filgrastim (G-CSF) mobilized peripheral blood stem cells (PBSC).
    Daugherty, CK
    Rudin, C
    Wagner, N
    Barker, S
    Larson, RA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A395 - A395
12345